Dr Irena Eris has submitted a prospectus to the Polish Financial Supervision Authority (KNF) in connection with the contemplated public offering and debut on the Warsaw Stock Exchange (WSE), the company said. The public offering of the shares is aimed at enabling the implementation of the group’s strategy both in the cosmetics segment and in the segment of premium hotel services.
“We are a dynamically developing family company, our products are eagerly chosen both in Poland and in over 60 countries around the world. The cosmetics segment generated almost 81% of our total revenues in 2021. In line with our idea of a holistic approach to caring for health and We also run three luxury SPA hotels in attractive spa and holiday regions in Poland. Observing the growing demand for premium hotel services in Poland, we plan to build another Dr Irena Eris SPA Hotel in Świnoujście,” said president Paweł Orfinger.
“We also want to increase the scale of our activity in the cosmetics segment, both through organic growth on new foreign markets and through acquisitions of attractive brands and cosmetics producers operating in Poland or abroad, in particular in the Central and Eastern Europe region. in order to enable the implementation of the strategy of Dr Irena Eris Group, both in the cosmetics segment and in the premium hotel services segment. The submission of the prospectus is the beginning of the road leading to the WSE, we will make final decisions in a few months,” he also said.
The chairman of the supervisory board, Henryk Orfinger, emphasized that over the course of almost 40 years, a small family-run establishment has been transformed into a large capital group, successfully operating in the segment of cosmetics and premium hotel services.
“We have proved that thanks to bold and thoughtful decisions, we are able to achieve the intended financial goals and increase the scale of operations. The plan to conduct a public offering and debut on the Warsaw Stock Exchange is a natural step in the further global development of the Dr Irena Eris Group,” he said.
“When I founded the company in 1983, we only produced one cream. Today we are one of the leaders of the Polish cosmetic market, with brands of premium cosmetics, dermocosmetics and mass cosmetics that are eagerly bought in dozens of countries around the world. is able to constantly expand and renew its product offer, creating new recipes. Our great advantage is our experienced staff, our own Dr Irena Eris Science and Research Center and a modern production plant, where we develop and produce a diverse range of cosmetics addressed to a very wide group of customers,” she added co-founder and board member Irena Eris.
The Dr Irena Eris Group is one of the leading Polish cosmetics producers and the owner of brands recognized in Poland and in the world: Dr Irena Eris, Pharmaceris, Emotopic, Lirene and Under Twenty. The company also operates a chain of three luxury hotels under the Dr Irena Eris SPA Hotels brand in Krynica-Zdrój (Małopolska), Wzgórze Dylewskie (Western Masuria) and in Polanica-Zdrój (Kotlina Kłodzka). The group plans to build a new five-star luxury hotel under the same brand in Świnoujście. Established in 1983, the company has been developing as a family business for nearly 40 years.
The company’s activity in the cosmetics segment focuses on the production of: premium cosmetics under the Dr Irena Eris brand (including face and body care and makeup lines), dermocosmetics (including medical devices) under the Pharmaceris and Emotopic brands, including specialist pharmacy products , enabling comprehensive care of problem skin, and mass market cosmetics under the Lirene and Under Twenty brands.
The cosmetics segment also includes the activities of Dr Irena Eris Cosmetic Institutes and Dr Irena Eris Beauty Partner, which have been developed for over 20 years. Currently, the Group has a total of 25 salons, operated mainly in the franchise model (4 own salons, 3 salons in Dr Irena Eris SPA Hotels, 12 municipal institutes and 6 developed in the Dr Irena Eris Beauty Partner concept in four and five-star hotels).
The Dr Irena Eris Group achieved PLN 297.6 million in sales revenues, and the net profit amounted to PLN 25.72 million in 2021.
The activities in the cosmetics segment in 2019 accounted for 79.4% of the group’s revenues, in 2020 – 80.8% of the group’s revenues, and in 2021 the cosmetics segment generated 80.9% of revenues. The premium hotel services segment, in the same periods, accounted for 20.6% of the group’s revenues in 2019, 19.2% of the group’s revenues in 2020 and 19.1% of the group’s revenues in 2021.
The cosmetics produced by the company are sold in beauty salons, perfumeries, drugstores, pharmacies, supermarkets and online stores. in 67 countries around the world. The export of the company’s products accounted for 25% of the revenues from the sale of cosmetics in 2019, 29% of the revenues in 2020 and 32% of the revenues in 2021.
The group employs a total of 850 people, of which 525 in the cosmetics segment and 325 in the premium hotel services segment.
Source: Dr Irena Eris and ISBnews
